Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Neupath Health Inc. ( (TSE:NPTH) ) is now available.
NeuPath Health Inc. announced it will release its Q3 2025 financial results on November 13, 2025, before the market opens. The company will host a live webinar featuring CEO Joe Walewicz to discuss the results, operations, and strategic outlook. This announcement is significant for investors and stakeholders as it provides insights into NeuPath’s operational performance and strategic direction in the healthcare industry.
The most recent analyst rating on (TSE:NPTH) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Neupath Health Inc. stock, see the TSE:NPTH Stock Forecast page.
More about Neupath Health Inc.
NeuPath Health Inc. operates a network of healthcare clinics in Ontario and Alberta, focusing on chronic pain treatment, musculoskeletal injuries, sports injuries, and concussions. The company also provides workplace health services and independent medical assessments through a national network, as well as contract research services to pharmaceutical and biotechnology companies.
Average Trading Volume: 85,379
Technical Sentiment Signal: Buy
Current Market Cap: C$21.19M
Learn more about NPTH stock on TipRanks’ Stock Analysis page.